Literature DB >> 2818454

Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations.

G Hasenfuss1, C Holubarsch, E M Blanchard, L A Mulieri, N R Alpert, H Just.   

Abstract

The influence of isoproterenol on myocardial performance and energetics was investigated in normal guinea pig myocardium and in patients with normal left ventricular function. The in vitro experiments were performed by simultaneous isometric force and heat measurements using sensitive antimony-bismuth thermopiles. Following the application of isoproterenol (10(-8) M) isometric peak twitch tension and tension-time integral increased significantly by 185% and 142%, respectively. Tension-independent heat which reflects high energy phosphate hydrolysis of excitation-contraction coupling increased by 183%. Tension-dependent heat reflecting the high energy phosphate hydrolysis of the crossbridges increased by 417%. The ratio of tension-dependent heat to tension-time integral increased by 131%. The recovery/initial heat ratio, reflecting the efficiency of the recovery metabolism, and the resting metabolism did not significantly change. In the patients the effect of isoproterenol on myocardial energetics was evaluated in terms of myocardial efficiency. Following isoproterenol administration, left ventricular systolic stress-time integral decreased by 49% due to reductions in end-diastolic pressure, end-diastolic volume and duration of systole. Pressure-volume work remained unchanged. Myocardial oxygen consumption per minute increased in proportion to heart rate. The ratio of myocardial oxygen consumption per beat to left ventricular systolic stress-time integral increased significantly by 95%. External myocardial efficiency was unaltered. Thus, isoproterenol increases the energy turnover of excitation-contraction coupling and increases the energy consumption of the crossbridges disproportionately to developed tension-time integral in the guinea pig heart.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2818454     DOI: 10.1007/BF02650354

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  23 in total

1.  ISOPROTERENOL AND CARDIOVASCULAR PERFORMANCE.

Authors:  N KRASNOW; E L ROLETT; P M YURCHAK; W B HOOD; R GORLIN
Journal:  Am J Med       Date:  1964-10       Impact factor: 4.965

2.  Metal-film thermopiles for use with rabbit right ventricular papillary muscles.

Authors:  L A Mulieri; G Luhr; J Trefry; N R Alpert
Journal:  Am J Physiol       Date:  1977-11

3.  The use of single plane angiocardiograms for the calculation of left ventricular volume in man.

Authors:  H Sandler; H T Dodge
Journal:  Am Heart J       Date:  1968-03       Impact factor: 4.749

4.  Mechanism of increase of myocardial oxygen uptake produced by catecholamines.

Authors:  F J Klocke; G A Kaiser; J Ross; E Braunwald
Journal:  Am J Physiol       Date:  1965-11

5.  Adrenaline increases the rate of cycling of crossbridges in rat cardiac muscle as measured by pseudo-random binary noise-modulated perturbation analysis.

Authors:  J F Hoh; G H Rossmanith; L J Kwan; A M Hamilton
Journal:  Circ Res       Date:  1988-03       Impact factor: 17.367

6.  Increased myothermal economy of isometric force generation in compensated cardiac hypertrophy induced by pulmonary artery constriction in the rabbit. A characterization of heat liberation in normal and hypertrophied right ventricular papillary muscles.

Authors:  N R Alpert; L A Mulieri
Journal:  Circ Res       Date:  1982-04       Impact factor: 17.367

7.  Calcium transients in mammalian ventricular muscle.

Authors:  D G Allen; S Kurihara
Journal:  Eur Heart J       Date:  1980       Impact factor: 29.983

8.  Myocardial oxygen use during epinephrine administration to ischemically injured canine hearts.

Authors:  J Lekven; L A Brunsting; M E Jessen; A S Abd-Elfattah; N E Doherty; A S Wechsler
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

9.  Energetic aspects of inotropic interventions in rat myocardium.

Authors:  G Hasenfuss; C Holubarsch; H Just; E Blanchard; L A Mulieri; N R Alpert
Journal:  Basic Res Cardiol       Date:  1987       Impact factor: 17.165

10.  Cyclic adenosine monophosphate effects on the myocardium: a man who blows hot and cold with one breath.

Authors:  A M Katz
Journal:  J Am Coll Cardiol       Date:  1983-07       Impact factor: 24.094

View more
  5 in total

Review 1.  Pharmacological treatment of chronic heart failure.

Authors:  Rachele Adorisio; Leonardo De Luca; Joseph Rossi; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

2.  Effects of treatment with a 5-HT4 receptor antagonist in heart failure.

Authors:  J A K Birkeland; I Sjaastad; T Brattelid; E Qvigstad; E R Moberg; K A Krobert; R Bjørnerheim; T Skomedal; O M Sejersted; J-B Osnes; F O Levy
Journal:  Br J Pharmacol       Date:  2006-12-11       Impact factor: 8.739

Review 3.  Cardiomyocyte Ca2+ homeostasis as a therapeutic target in heart failure with reduced and preserved ejection fraction.

Authors:  Deborah Peana; Timothy L Domeier
Journal:  Curr Opin Pharmacol       Date:  2017-04-22       Impact factor: 5.547

4.  Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.

Authors:  Sheryl E Koch; Michael Tranter; Nathan Robbins; Kristin Luther; Umesh Singh; Min Jiang; Xiaoping Ren; Trisha Tee; Leah Smith; Priyanka Varma; W Keith Jones; Jack Rubinstein
Journal:  J Cardiovasc Pharmacol Ther       Date:  2012-12-14       Impact factor: 2.457

Review 5.  Cardiac efficiency.

Authors:  J D Schipke
Journal:  Basic Res Cardiol       Date:  1994 May-Jun       Impact factor: 17.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.